SS Innovations International (SSII) Non-Current Assets (2016 - 2026)
SS Innovations International (SSII) reported Non-Current Assets of $24.3 million for Q1 2026, up 53.35% on a YoY basis from $15.8 million in Q1 2025, and down 4.59% sequentially from $25.5 million in Q4 2025.
SS Innovations International (SSII) Non-Current Assets (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Non-Current Assets data on file, last reported at $24.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 53.35% year-over-year to $24.3 million; the trailing twelve-month figure through Mar 2026 stood at $90.1 million (up 468.8% YoY), and the FY2025 full-year result was $25.5 million, up 70.04% from the prior year.
- Non-Current Assets eased to $24.3 million in Q1 2026, from $25.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $25.5 million in Q4 2025 to a low of $9120.0 in Q1 2023.
- A 5-year average of $10.7 million and a median of $11.6 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets sank 89.22% in 2022 and jumped 127202.95% in 2024, its largest moves.
- Tracing SSII's Non-Current Assets over 5 years: stood at $2.9 million in 2022, then soared by 249.61% to $10.1 million in 2023, then soared by 48.39% to $15.0 million in 2024, then jumped by 70.04% to $25.5 million in 2025, then decreased by 4.59% to $24.3 million in 2026.
- Business Quant data shows SSII's Non-Current Assets at $24.3 million in Q1 2026, $25.5 million in Q4 2025, and $21.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 24.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.29 Mn |
| Dec 31, 2025 | 25.45 Mn |
| Sep 30, 2025 | 21.15 Mn |
| Jun 30, 2025 | 19.19 Mn |
| Mar 31, 2025 | 15.84 Mn |
| Dec 31, 2024 | 14.97 Mn |
| Sep 30, 2024 | 13.94 Mn |
| Jun 30, 2024 | 12.40 Mn |
| Mar 31, 2024 | 11.61 Mn |
| Dec 31, 2023 | 10.09 Mn |
| Sep 30, 2023 | 5.44 Mn |
| Jun 30, 2023 | 4.78 Mn |
| Mar 31, 2023 | 9,120.00 |
| Dec 31, 2022 | 2.89 Mn |
| Sep 30, 2022 | 13,678.00 |
| Jun 30, 2022 | 15,957.00 |
| Mar 31, 2022 | 18,237.00 |
| Dec 31, 2021 | 20,542.00 |
| Sep 30, 2021 | 126,916.00 |
| Jun 30, 2021 | 130,182.00 |